This inventor holds 2 USPTO granted patents. Top assignee: Intelligent Synthetic Biology Center. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Innovations of Kyung Sun Choi in Cancer Treatment
Introduction
Kyung Sun Choi is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of new pharmaceutical compositions. With a total of 2 patents, his work focuses on utilizing ginsenoside compounds for therapeutic applications.
Latest Patents
Kyung Sun Choi's latest patents include an anticancer adjuvant containing panaxadiol ginsenoside compounds. This invention relates to a pharmaceutical composition that aids in treating cancer by utilizing protopanaxadiol (PPD) or compound-K. The anticancer adjuvant damages mitochondria in cancer cells, enhancing mitochondria-mediated anticancer activity. This innovative approach can lead to safer treatment options for cancer patients.
Another significant patent is a method for screening regulators of mitochondrial fission. This method employs a cell treated with a PPD-type ginsenoside compound, allowing for the effective discovery of formulations that can prevent or treat mitochondria-related diseases. This invention holds promise for the development of therapeutic agents targeting such diseases.
Career Highlights
Kyung Sun Choi is affiliated with the Intelligent Synthetic Biology Center, where he continues to advance his research in synthetic biology and cancer treatment. His work is characterized by a commitment to improving therapeutic strategies and enhancing patient outcomes.
Collaborations
Kyung Sun Choi collaborates with esteemed colleagues, including Chul Hee Choi and Eun Soo Kim. Their combined expertise fosters a productive research environment that drives innovation in the field of synthetic biology and cancer therapy.
Conclusion
Kyung Sun Choi's contributions to cancer treatment through his innovative patents highlight the potential of ginsenoside compounds in therapeutic applications. His ongoing research at the Intelligent Synthetic Biology Center promises to further advance the field and improve treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile